UCB (company)
Belgian multinational biopharmaceutical company
UCB S.A. is a multinational biopharmaceutical company headquartered in Brussels, Belgium. It specializes in the research, development, and commercialization of innovative medicines and solutions to improve the lives of people with severe diseases in the fields of neurology and immunology.
History[edit | edit source]
UCB was founded in 1928 by Emmanuel Janssen as a chemical company. Initially, it focused on industrial chemicals, but over the decades, it shifted its focus towards pharmaceuticals. The company made significant strides in the pharmaceutical industry in the 1950s and 1960s, leading to its current status as a leader in biopharmaceuticals.
Research and Development[edit | edit source]
UCB is committed to advancing scientific research and development. The company invests heavily in R&D, with a focus on discovering and developing new therapies for neurological disorders and autoimmune diseases. UCB's research facilities are located in several countries, including Belgium, the United States, and the United Kingdom.
Neurology[edit | edit source]
In the field of neurology, UCB has developed treatments for conditions such as epilepsy, Parkinson's disease, and restless legs syndrome. The company's flagship product in this area is levetiracetam, marketed under the brand name Keppra, which is used to treat epilepsy.
Immunology[edit | edit source]
UCB's immunology division focuses on developing therapies for autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease. One of its notable products is certolizumab pegol, marketed as Cimzia, which is used to treat several inflammatory conditions.
Global Presence[edit | edit source]
UCB operates in over 40 countries worldwide, with major markets in Europe, North America, and Asia. The company employs thousands of people globally and collaborates with various academic and research institutions to advance its scientific goals.
Corporate Social Responsibility[edit | edit source]
UCB is committed to corporate social responsibility and sustainability. The company engages in various initiatives to reduce its environmental impact, promote ethical business practices, and support communities where it operates.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
